J&J | JNJ - Current Assets



J&J reported $71.55B in Current Assets for its fiscal quarter ending in March of 2025.


Current Assets Change Date
AbbVie USD 27.68B 2.09B Mar/2025
Abbott USD 24.47B 1.32B Jun/2025
Amgen USD 26.73B 195M Jun/2025
AstraZeneca USD 28.94B 2.8B Jun/2025
Baxter International USD 7.04B 1.82B Mar/2025
Bayer EUR 33.75B 1.08B Jun/2025
Becton, Dickinson and Co. USD 9B 331M Jun/2025
Biogen USD 7.97B 341.7M Jun/2025
Boston Scientific USD 7.34B 415M Mar/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
CONMED USD 657.78M 18.78M Jun/2025
Cooper Companies USD 2.14B 12.1M Jul/2025
Dexcom USD 5.03B 476.4M Jun/2025
Edwards Lifesciences USD 6.21B 72.7M Mar/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
Gilead Sciences USD 14.72B 2.18B Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Globus Medical USD 1.73B 19.79M Jun/2025
Hologic USD 3.42B 212.7M Jun/2025
Insulet USD 2.28B 48.7M Jun/2025
Integra LifeSciences USD 1.14B 35.58M Jun/2025
Intuitive Surgical USD 12.47B 592.4M Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Medtronic USD 23.81B 1.3B Apr/2025
Merck USD 37.07B 1.56B Jun/2025
Merit Medical Systems USD 923.07M 35.56M Jun/2025
Novartis USD 25.94B 831M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Regeneron Pharmaceuticals USD 16.86B 712.2M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sanofi 37.02B 7B Jun/2025
Stryker USD 13B 19M Jun/2025
Tandem Diabetes Care USD 614.82M 48.62M Jun/2025
Teva Pharmaceutical Industries USD 12.62B 1.09B Jun/2025
Vertex Pharmaceuticals USD 10.43B 419.1M Jun/2025
Zimmer Biomet Holdings USD 5.05B 536.3M Jun/2025
Zoetis USD 5.92B 46M Jun/2025